US Stem Cell Inc (USRM)

[Dragon Lady]

AARP, 23 MILLION READERS...FDA USSC CRACKDOWN !!

http://www.aarp.org/health/conditions-treatments/info-2017/fda-monitoring-stem-cell-clinics.html

AARP is thee single HIGHEST CIRCULATION and MOST READ magazine in America, with 23 MILLION plus circulation....AND THEY COVERED THE U.S. Stem Cell FDA WARNING "CRACKDOWN" as they call it. AARP even mentions the USRM THREE BLIND LADIES incident again, keeping that fiasco alive and well.

https://en.wikipedia.org/wiki/List_of_magazines_by_circulation

TIME magazine is the 13th most circulated magazine in America with 3 MILLION plus readers, is almost 100 years old being in-print since 1923 making it one of the most TRUSTED NEWS SOURCES in the nation, and it also has a huge international circulation to boot, and they covered the U.S. Stem Cell and Comella FDA WARNING LETTER and then interviewed new FDA Commissioner Scott Gottlieb who called USSC "UNSCRUPULOUS" and "A BAD ACTOR" quoted directly in the TIME mag piece:

time.com/4920259/fda-crackdown-stem-cell-clinics/

This kind of coverage will BURY THIS COMPANY IMO. You can't get any worse press coverage if you ask me- add in NPR and the top 5 newspapers in this nation such as the NY Times and L.A. Times all running coverage on the FDA enforcement action(s) targeting USRM and their subsidiary clinic U.S. Stem Cell AND Kristin Comella and it's pretty clear to me why "STEM CELL CENTERS OF EXCELLENCE" just yanked Comella's picture and "SHE'S OUR TEAM" and "SHE'S OUR CHIEF SCIENCE OFFICER" blah, blah off their website, LOL !!!

TOXIC is what its become if you ask me....LOL...a HOT POTATO...where they gonna raise investment money now for their dire financial GOING CONCERN and LIQUIDITY PROBLEMS WARNINGS in their most recent SEC 10-Q???

https://www.sec.gov/Archives/edgar/data/1388319/000118518517001674/usstemcell10q063017.htm

PAGE 12:

"NOTE 2 – GOING CONCERN AND MANAGEMENT’S LIQUIDITY PLANS

The accompanying condensed financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As shown in the accompanying financial statements during six months ended June 30, 2017, the Company incurred net losses of $2,896,674 and has a working capital deficit (current liabilities in excess of current assets) of $5,409,586. These factors among others may indicate that the Company will be unable to continue as a going concern for a reasonable period of time.

The Company’s primary source of operating funds in 2016 and 2017 has been from revenue generated from sales and cash proceeds from the sale of common stock and the issuance of convertible and other debt. The Company has experienced net losses and negative cash flows from operations since inception, but expects these conditions to improve in the second half of in 2017 and beyond as it develops its business model. The Company has stockholders’ deficiencies at June 30, 2017 and requires additional financing to fund future operations.

The Company’s existence is dependent upon management’s ability to develop profitable operations, to obtain additional funding sources and realize revenues from the Asset Sale and Lease Agreement described herein. There can be no assurance that the Company’s financing efforts or revenues realized from the Asset Sale and Lease Agreement will result in profitable operations or the resolution of the Company’s liquidity problems. "


GOING CONCERN and LIQUIDITY PROBLEMS and WE DON'T SURVIVE W/O FURTHER "FINANCING" as we "RUN DEFICITS" ......PLAIN ENGLISH....and now they got the FDA all over um....who's gonna "finance" this mess....WHO ???